Archive du jour : mars 2, 2022

Fig. 3 The quantitative analysis of pulmonary inflammation of lung samples from PBS control group, prophylaxis group and treatment group. © Nat Immunol

02/03/2022

Des scientifiques chinois conçoivent un cocktail d’anticorps pour le traitement et la prévention

BEIJING, 2 mars (Xinhua) — Des scientifiques chinois ont conçu un cocktail d’anticorps pouvant donner un double coup au coronavirus responsable de la COVID-19. Les chercheurs de l’Université de médecine de la Capitale et de l’Académie des sciences de Chine ont mis au point l’anticorps monoclonal humain bispécifique contre le SRAS CoV-2, combinant une paire d’anticorps neutralisants humains non concurrents, à savoir B38 et H4, pour cibler deux antigènes, empêchant ainsi le virus de se lier à son récepteur.

Presse

02/03/2022

[Japon] COVID-19 is forcing some Japanese hospitals to limit conventional care

The sixth wave of the pandemic may have crested but the number of COVID-19 patients requiring hospitalization remains high, further straining Japan’s health care system and making it hard for some hospitals to continue offering other conventional medical services.

A government pandemic adviser has called on private hospitals to do their part in dealing with the surging number of coronavirus patients in Hong Kong. © Jonathan Wong

Presse

02/03/2022

[Hong Kong] Hong Kong has no plans for ‘wholesale city lockdown’, leader Carrie Lam insists, as record 55,000 new Covid-19 cases confirmed

– Carrie Lam says government is still refining the details, and while there will be some form of plan ‘limiting individual movements’ a complete lockdown will not happen
– Sources say universal testing could begin on March 26 and last for nine days under a preliminary plan